Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
13 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/13/3042602/0/en/Shuttle-Pharma-Announces-Closing-of-5-75-Million-Underwritten-Offering.html
12 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/12/3041194/0/en/Shuttle-Pharma-Announces-Appointment-of-Christopher-Cooper-as-Interim-Co-CEO-to-Enhance-Business-Activities.html
12 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/12/3041437/0/en/Shuttle-Pharma-Announces-Pricing-of-5-75-Million-Underwritten-Offering.html
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3033099/0/en/Shuttle-Pharma-Provides-Corporate-Update-and-Reports-2024-Results.html
21 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/21/3012743/0/en/Shuttle-Pharma-Reaches-Milestone-in-Patient-Enrollment-for-Phase-2-Clinical-Trial-of-Ropidoxuridine-for-Treatment-of-Patients-with-Glioblastoma.html
07 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/07/3005479/0/en/Shuttle-Pharma-to-Participate-in-the-Lytham-Partners-2025-Investor-Healthcare-Summit-on-January-13-2025.html
ABOUT THIS PAGE